Hepatic T cells and liver tolerance

Nature Reviews Immunology

Volumn 3, Issue 1, 2003, Pages 51-62

  Crispe, Ian Nicholas ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR1; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; APOPTOSIS; DENDRITIC CELL; GRAFT SURVIVAL; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; KUPFFER CELL; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; HEPATITIS B; HEPATITIS C; IMMUNOLOGY; LIVER CIRCULATION; MALARIA; METABOLISM;

ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNE TOLERANCE; LIVER; LIVER CIRCULATION; LIVER TRANSPLANTATION; MALARIA;

EID: 0037270978     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri981     Document Type: Review

References (169)

1. Wang, C. H., Tschen, S. Y., Heinricy, U., Weber, M. & Flehmig, B. Immune response to hepatitis A virus capsid proteins after infection. J. Clin. Microbiol. 34, 707-713 (1996).
2. Homberger, F. R. Enterotropic mouse hepatitis virus. Lab. Anim. 31, 97-115 (1997).
3. Lavi, E. & Wang, Q. The protective role of cytotoxic T cells and interferon against coronavirus invasion of the brain. Adv. Exp. Med. Biol. 380, 145-149 (1995).
4. Good, M. F. Development of immunity to malana may not be an entirely active process. Parasite Immunol. 17, 55-59 (1995).
5. Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2, 1104-1108 (1996).
6. Spengler, U., Lechmann, M., Irrgang, B., Dumoulin, F. L. & Sauerbruch, T. Immune responses in hepatitis C virus infection. J. Hepatol. 24, 20-25 (1996).
7. Calne, R. Y. et al. Induction of immunological tolerance by porcine liver allografts. Nature 223, 472-476 (1969).
8. van der Bruggen, P. et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647 (1991).
9. Braet, F., Luo, D., Spector, I., Vermijlen, D. & Wisse, E. in The Liver Biology and Pathobiology (eds Arias, I. et al.) 437-453 (Lippincott, Williams and Wilkins, Philadelphia, 2001).
10. Wisse, E. in The Reticuloendothelial System. A Comprehensive Treatise (eds Carr, I. & Daems, W. T.) 361-377 (Plenum, New York and London, 1980).
11. MacPhee, P. J., Schmidt, E. E. & Groom, A. C. Evidence for Kupffer-cell migration along liver sinusoids, from high-resolution in vivo microscopy. Am. J. Physiol. 263, G17-G23 (1992).
12. Shi, J., Fujieda, H., Kokubo, Y. & Wake, K. Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 24, 1256-1263 (1996).
13. Ruzittu, M., Carla, E. C., Montinari, M. R., Maietta, G. & Dini, L. Modulation of cell-surface expression of liver carbohydrate receptors during in vivo induction of apoptosis with lead nitrate. Cell Tissue Res. 298, 105-112 (1999).
14. Filice, G. A. Antimicrobial properties of Kupffer cells. Infect. Immun. 56, 1430-1435 (1988).
15. Wardle, E. N. Kupffer cells and their function. Liver 7, 63-75 (1987)
16. Ruggiero, G. et al. Clearance of viable Calmette-Guerin bacillus by the in vitro isolated and perfused rat liver. Acta Hepatogastroenterol. (Stuttg.) 24, 102-105 (1977).
17. Rogoff, T. M. & Lipsky, P. E. Antigen presentation by isolated guinea-pig Kupffer cells. J. Immunol. 124, 1740-1744 (1980).
18. + T-lymphocyte clone to Listeria monocytogenes. Infect. Immun. 58, 2313-2319 (1990).
19. H1 lymphocyte depends on the inducibility of nitric oxide synthase by iFN-γ. J. Immunol. 153, 5453-5464 (1994).
20. Yu, S., Nakafusa, Y. & Flye, M. W. Portal-vein adminstration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 116, 229-234 (1994).
21. Roland, C. R., Mangino, M. J., Duffy, B. F. & Flye, M. W. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium. Transplantation 55, 1151-1158 (1993).
22. Norris, S. et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28, 84-90 (1998).
23. Crispe, I. N. & Mehal, W. Z. Strange brew: T cells in the liver Immunol. Today 17, 522-525 (1996).
24. Pruvot, F. R. et al. Characterization, quantification and localization of passenger T lymphocytes and NK cells in human liver before transplantation. Transpl. Int. 8, 273-279 (1995).
25. + T cells by the normal liver. J. Immunol. 163, 3202-3210 (1999).
26. Klugewitz, K. et al Differentiation-dependent and subset-specific recruitment of T-helper cells into murine liver. Hepatology 35, 568-578 (2002).
27. + effector cells and suppression of IFN-γ -producing cells after intravenous protein immunization. J. Immunol. 169, 2407-2413 (2002).
28. - T cells in the normal mouse liver. Int. Immunol. 6, 533-540 (1994).
29. Renno, T., Hahne, M., Tschopp, J. & MacDonald, H. R. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183, 431-437 (1996).
30. + T cells is accompanied by liver lymphocytosis, intrahepatic T-cell apoptosis and hepatocyte damage.
31. Bouwens, L., Remels, L., Baekeland, M., Van Bossuyt, H. & Wisse, E. Large granular lymphocytes or 'pit cells' from rat liver: isolation, ultrastructural characterization and natural killer activity. Eur. J. Immunol. 17, 37-42 (1987).
32. McIntyre, K. W. & Welsh, R. M. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164, 1667-1681 (1986).
33. + T cells for concanavalin-A-induced hepatic injury in mice. J. Immunol. 159, 1537-1542 (1997).
34. Liu, Z. X., Govindarajan, S., Okamoto, S. & Dennert, G. NK cells cause liver injury and facilitate the induction of T-cell-mediated immunity to a viral liver infection. J. Immunol. 164, 6480-6486 (2000).
35. Salazar-Mather, T. P., Orange, J. S. & Biron, C. A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK-cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187, 1-14 (1998).
36. Itoh, Y. et al. Time-course profile and cell-type-specific production of monokine induced by interferon-γ in concanavalin-A-induced hepatic injury in mice: comparative study with interferon-inducible protein-10. Scand. J. Gastroenterol. 36, 1344-1351 (2001).
37. Watanabe, H. et al. Characterization of intermediate TCR cells in the liver of mice with respect to their unique IL-2R expression. Cell. Immunol. 149, 331-342 (1993).
38. MacDonald, H. R. Development and selection of NKT cells. Curr. Opin. Immunol. 14, 250-254 (2002).
39. MacDonald, H. R. Vα14 NKT cells - a novel lymphoid cell lineage. Jpn J. Cancer Res. 88, inside front cover (1997).
40. Eberl, G. et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NKT cells. J. Immunol. 162, 6410-6419 (1999).
41. Baron, J. L. et al. Activation of a nonclassical NKT-cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594 (2002).
42. Benlagha, K., Kyin, T., Beavis, A., Teyton, L. & Bendelac, A. A thymic precursor to the NKT-cell lineage. Science 296, 553-555 (2002).
43. Sato, K. et al. Evidence for extrathymic generation of intermediate T-cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone-marrow transplantation. J. Exp. Med. 182, 759-767 (1995).
44. + T cells. J. Immunol. 164, 2009-2015 (2000).
45. + T cells. J. Immunol. 169, 1444-1452 (2002).
46. + thymocytes. Eur. J. Immunol. 26, 1424-1429 (1996).
47. Mars, L. T. et al. Cutting edge: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J. Immunol. 168, 6007-6011 (2002).
48. H2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166, 3749-3756 (2001).
49. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C. R. & Brenner, M. B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189, 1973-1980 (1999).
50. Kumar, H., Belperron, A., Barthold, S. W. & Bockenstedt, L. K. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete. Borrella burgdorferi. J. Immunol. 165, 4797-4801 (2000).
51. Duthie, M. S. & Kahn, S. J. Treatment with α -galactosyl-ceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168, 5778-5785 (2002).
52. Duthie, M. S. et al. During Trypanosoma cruzi infection CD1d-restricted NKT cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70, 36-48 (2002).
53. Romero, J. F., Eberl, G., MacDonald, H. R. & Corradin, G. CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver-stage malaria infection in mice. Parasite Immunol. 23, 267-269 (2001).
54. Dao, T. et al. Involvement of CD1 in peripheral deletion of T lymphocytes is independent of NK T cells. J. Immunol. 168, 3090-3097 (2001).
55. Cui, J. et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
56. Crowe, N. Y., Smyth, M. J. & Godfrey, D. I. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196, 119-127 (2002).
57. Matsuda, J. L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp. Med. 192, 741-754 (2000).
58. Toura, I. et al. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163, 2387-2391 (1999).
59. Gonzalez-Aseguinolaza, G. et al. α-galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97, 8461-8466 (2000).
60. Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisan, F. V. Natural killer T-cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930 (2000).
61. Norris, S. et al. Natural T cells in the human liver: cytotoxic lymphocytes with dual T-cell and natural-killer-cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T-cell-receptor-bearing cells. Hum. Immunol. 60, 20-31 (1999).
62. Collins, C. et al. RAG1, RAG2 and pre-T-cell receptor α-chain expression by adult human hepatic T cells: evidence for extrathymic T-cell maturation. Eur. J. Immunol. 26, 3114-3118 (1996).
63. Crosbie, O. M. et al. In vitro evidence for the presence of hemetopoietic stem cells in the adult human liver. Hepatology 29, 1193-1198 (1999).
64. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-16 production from Kupffer cells. J. Immunol. 159, 97-106 (1997).
65. Guebre-Xabier, M. et al. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology 31, 633-640 (2000).
66. Minagawa, M. et al. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 31, 907-915 (2000).
67. Gossmann, J., Lohler, J., Utermohlen, O. & Lehmann-Grube, F. Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. Lab. Invest. 72, 559-570 (1995).
68. Kakumu, S. et al. Comparisons of peripheral blood and hepatic lymphocyte subpopulations and interferon production in chronic viral hepatitis. J. Clin. Lab. Immunol. 33, 1-6 (1990).
69. + ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin. Exp. Immunol. 97, 403-410 (1994).
70. Fiore, G. et al. CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C. Microbios. 92, 73-82 (1997).
71. Tseng, C. T., Miskovsky, E., Houghton, M. & Kimpel, G. R. Characterization of liver T-cell receptor γδ T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 33, 1312-1320 (2001).
72. Crispe, I. N., Dao, T., Klugewitz, K., Mehal, W. Z. & Metz, D. P. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 174, 47-62 (2000).
73. Volpes, R., van den Oord, J. J. & Desmet, V. J. Hepatic expression of intercellular adhesion molecule-1 (ICAM-1) in viral hepatitis B. Hepatology 12, 148-154 (1990).
74. Garcia-Monzon, C. et al. Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts. Gastroenterology 108, 231-241 (1995).
75. Mochizuki, K. et al. B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. Hepatology 25, 713-718 (1997).
76. Hiramatsu, N. et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354-1359 (1994).
77. Butcher, E. C., Williams, M., Youngman, K., Rott, L. & Briskin, M. Lymphocyte trafficking and regional immunity. Adv. Immunol. 72, 209-253 (1999).
78. Wong, J. et al. A minimal role for selectins in the recruitment of leukocytes into the inflamed liver microvasculature. J. Clin. Invest. 99, 2782-2790 (1997).
79. Iigo, Y. et al. Constitutive expression of ICAM-1 in rat microvascular systems analyzed by laser confocal microscopy. Am. J. Physiol. 273, H138-H147 (1997).
80. McNab, G. et al. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 110, 522-528 (1996).
81. Harju, K., Glumoff, V. & Hallman, M. Ontogeny of Toll-like receptors Tlr2 and Tlr4 in mice. Pediatr. Res. 49, 81-83 (2001).
82. Faure, E. et al. Bacterial lipopolysaccharide and IFN-γ induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-κB activation. J. Immunol. 166, 2018-2024 (2001).
83. van Oosten, M., van de Bilt, E., de Vries, H. E., van Berkel, T. J. & Kuiper, J. Vascular adhesion molecule-1 and intercellular adhesion molecule-1 expression on rat liver cells after lipopolysaccharide administration in vivo. Hepatology 22, 1538-1546 (1995).
84. Matsuno, K., Ezaki, T., Kudo, S. & Uehara, Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis and translocation from the liver to the draining lymph. J. Exp. Med. 183, 1865-1878 (1996).
85. Dieu, M. C. et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373-386 (1998).
86. Saeki, H., Moore, A. M., Brown, M. J. & Hwang, S. T. Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC-chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162, 2472-2475 (1999).
87. Yoneyama, H. et al. Regulation by chemokines of circulating dendritic-cell precursors, and the formation of portal tract-associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 193, 35-49 (2001).
88. Prickett, T. C., McKenzie, J. L. & Hart, D. N. Characterization of interstitial dendritic cells in human liver. Transplantation 46, 754-761 (1988).
89. Traver, D. et al. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290, 2152-2154 (2000).
90. + lymphoid-related dendritic cells. J. Immunol. 165, 795-803 (2000).
91. Uwatoku, R. et al. Kupffer-cell-mediated recruitment of rat dendritic cells to the liver: roles of N-acetylgalactosamine-specific sugar receptors. Gastroenterology 121, 1460-1472 (2001).
92. Uwatoku, R. et al. Asialoglycoprotein receptors on rat dendritic cells: possible roles for binding with Kupffer cells and ingesting virus particles. Arch. Histol. Cytol. 64, 223-232 (2001).
93. Higashi, N. et al. The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells. J. Biol. Chem. 277, 20686-20693 (2002).
94. Albert, M. L., Sauter, B. & Bhardwaj, N. Dendritic cells acquire antigen from apoptotic cells and induce class-I-restricted CTLs. Nature 392, 86-89 (1998).
95. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188, 1359-1368 (1998).
96. Lohse, A. W. et al. Antigen-presenting function and B7 expression of murine sinusoidal endothelial cells and Kupffer cells. Gastroenterology 110, 1175-1181 (1996).
97. H1 cells. Gastroenterology 116, 1428-1440 (1999).
98. + T cells results in antigen-specific T-cell tolerance. Nature Med. 6, 1348-1354 (2000). In this paper, Knolle and colleagues describe the unique properties of liver sinusoidal endothelial cells as antigen-presenting cells that promote tolerance.
99. Leifeld, L. et al. Enhanced expression of CD80 (B7-1), CD86 (B7-2) and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am. J. Pathol. 154, 1711-1720 (1999).
100. Masopust, D., Vezys, V. Marzo, A. L. & Lefrancois, L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291, 2413-2417 (2001).
101. Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T. & Jenkins, M. K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410, 101-105 (2001).
102. Ando, K., Guidotti, L. G., Cerny, A., Ishikawa, T. & Chisari, F. V. CTL access to tissue antigen is restricted in vivo. J. Immunol. 153, 482-488 (1994).
103. + T cells within the liver. J. Immunol. 166, 5430-5438 (2001).
104. + T lymphocytes but fail to promote survival. Eur. J. Immunol. 28, 221-236 (1998). One explanation for liver tolerance is that antigen presentation by non-professional antigen-presenting cells, such as hepatocytes, causes T-cell apoptosis. This paper describes experiments in favour of this theory.
105. Bertolino, P. et al. Death by neglect as a deletional mechanism of peripheral tolerance. Int. Immunol. 11, 1225-1238 (1999).
106. Qian, S. et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158, 4654-4661 (1997). Qian and colleagues show that apoptosis is an important feature of the lymphocyte influx to a liver allograft.
107. Meyer, D. et al. Apoptosis of alloreactive T cells in liver allografts during tolerance induction. Transplant. Proc. 31, 474 (1999).
108. Lohman, B. L., Razvi, E. S. & Welsh, R. M. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol 70, 8199-8203 (1996).
109. Lenardo, M. et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17, 221-253 (1999).
110. Rathmell, J. C. & Thompson, C. B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17, 781-828 (1999).
111. Slee, E. A., Adrain, C. & Martin, S. J. Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ. 6, 1067-1074 (1999).
112. Lenardo, M. J. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858-861 (1991).
113. Refaeli, Y., Ven Parijs, L., London, C. A., Tschopp, J. & Abbas, A. K. Biochemical mechanisms of IL-2-regulated Fas-mediated T-cell apoptosis. Immunity 8, 615-623 (1998)
114. Van Parijs, L., Refaeli, Y., Abbas, A. K. & Baltimore, D. Autoimmmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes. Immunity 11, 763-770 (1999).
115. Medema, J. P. et al. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804 (1997).
116. Lee, Y. C. et al. Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant. Proc. 31, 784 (1999).
117. DeSilva, D. R., Urdahl, K. B. & Jenkins, M. K. Clonal energy is induced in vitro by T-cell receptor occupancy in the absence of proliferation. J. Immunol. 147, 3261-3267 (1991).
118. Li, W. et al. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation 72, 1423-1432 (2001).
119. Liu, Z. X., Govindarajan, S., Okamoto, S. & Dennert, G. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J. Immunol. 166, 3035-3041 (2001).
120. Bonfoco, E. et al. Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity 9, 711-720 (1998).
121. + T-cell homeostasis by perforin and interferon-γ. Science 290, 1354-1358 (2000).
122. D'Amico, G. et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nature Immunol. 1, 387-391 (2000).
123. Takayama, T. et al. Mammalian and viral IL-10 enhance CC-chemokine receptor 5 but down-regulate CC-chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability. J. Immunol. 166, 7136-7143 (2001).
124. + T cells produce different cytokines during rejection and tolerance in response to stimulation. J. Gastrointest. Surg. 6, 455-463 (2002).
125. + T cells in vivo by IL-15. Immunity 8, 591-599 (1998).
126. Mattei, F., Schiavoni, G., Belardelli, F. & Tough, D. F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA or lipopolysaccharide and promotes dendritic-cell activation. J. Immunol. 167, 1179-1187 (2001).
127. Lutz, M. & Schuler, G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23, 445-449 (2002).
128. Christensen, H. R., Frokiaer, H. & Pestka, J. J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol. 168, 171-178 (2002).
129. Granucci, F., Vizzardelli, C., Virzi, E., Rescigno, M. & Ricciardi-Castagnoli, P. Transcriptional reprogramming of dendritic cells by differentiation stimuli. Eur. J. Immunol. 31, 2539-2546 (2001).
130. Luft, T. et al. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953 (1998).
131. Radvanyi, L. G., Banerjee, A., Weir M. & Messner, H. Low levels of interferon-α induce CD86 (B7.2) expression and accelerate dendritic-cell maturation from human peripheral-blood mononuclear cells. Scand. J. Immunol. 50, 499-509 (1999).
132. Kadowaki, N., Antonenko, S., Lau, J. Y. & Liu, Y. J. Natural interferon-αβ-producing cells link innate and adaptive immunity. J. Exp. Med. 192, 219-226 (2000).
133. Knolle, P. A. et al. Endotoxin down-regulates T-cell activation by antigen-presenting liver sinusoidal endothelial cells. J. Immunol. 162, 1401-1407 (1999).
134. Ogasawara, J. et al. Lethal effects of the anti-Fas antibody in mice. Nature 346, 806-809 (1993).
135. Schlosser, S. F. et al. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system. Hepatology 32, 779-785 (2000).
136. Kountouras, J., Boura, P. & Lygidakis, N. J. Liver regeneration after hepatectomy. Hepatogastroenterology 48, 556-562 (2001).
137. Malago, M., Rogiers, X. & Broelsch, C. E. Reduced-size hepatic allografts. Annu. Rev. Med. 46, 507-512 (1995).
138. + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc. Natl Acad. Sci. USA 93, 11774-11779 (1996).
139. Boismenu, R. & Havran, W. Modulation of epithelial-cell growth by intraepithelial γδ T cells. Science 266, 1253-1255 (1994).
140. Tamura, F. et al. FK506 promotes liver regeneration by suppressing natural killer cell activity. J. Gastroenterol. Hepatol. 13, 703-708 (1998).
141. Polimeno, L. et al. Molecular mechanisms of augmenter of liver regeneration as immunoregulator: its effect on interferon-7 expression in rat liver. Dig. Liver Dis. 32, 217-225 (2000).
142. + T cells triggered by high-affinity peptide antigens. J. Exp. Med. 188, 1147-1157 (1998).
143. + T cells is Fas dependent. J. Immunol. 167, 6654-6662 (2001).
144. Hayashi, N. & Mita, E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J. Viral Hepat. 6, 357-365 (1999).
145. Fiore, G. et al. Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities. Microbios. 97, 29-38 (1999).
146. Abe, S., Kotoh, K., Arao, S., Tabaru, A. & Otsuki, M. Fas antigen expression on hepatocytes predicts the short- and long-term response to interferon therapy in patients with chronic hepatitis C. Scand. J. Gastroenterol. 36, 326-331 (2001).
147. Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3, 409-413 (1997).
148. Bobe, P. et al. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease. J. Immunol. 159, 4197-4204 (1997).
149. Afford, S. C. et al. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell-surface Fas-ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection. J. Exp. Med. 189, 441-446 (1999).
150. Alter, H. J. & Seeff, L. B. Recovery, persistence and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20, 17-35 (2000).
151. Wong, D. K. et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J. Immunol. 160, 1479-1488 (1998).
152. + T-lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30, 2479-2487 (2000).
153. Lechner, F. et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191, 1499-1512 (2000).
154. Cooper, S. et al. Analysis of a successful immune response against hepatitis C virus. Immunity 10, 439-449 (1999). This paper shows the importance of the magnitude and diversity of the cytotoxic T-lymphocyte response in determining the outcome of hepatitis C virus infection.
155. Weiner, A. et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl Acad Sci. USA 92, 2755-2759 (1995).
156. Erickson, A. L. et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15, 883-895 (2001).
157. Chang, K. M. et al. Immunological significance of cytotoxic T-lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100, 2376-2385 (1997).
158. + T cells. J. Immunol. 163, 650-658 (1999).
159. + T lymphocytes after infection with hepatitis C virus. J. Virol. 75, 5550-5558 (2001).
160. Kittlesen, C. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J. & Hahn, Y. S. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J. Clin. Invest. 106, 1239-1249 (2000).
161. Yao, Z. Q., Nguyen, D. T., Hiotellis, A. I. & Hahn, Y. S. Hepatitis C virus core protein inhibits human T-lymphocyte responses by a complement-dependent regulatory pathway. J. Immunol. 167, 5264-5272 (2001).
162. Hahn, C. S., Cho, Y. G., Kang, B. S., Lester, I. M. & Hahn, Y. S. The HCV core protein acts as a positive regulator of Fas-mediated apoptosis in a human lymphoblastoid T-cell line. Virology 216, 127-137 (2000).
163. Crotta, S. et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195, 35-42 (2002).
164. Sun, J. et al. Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol. 75, 11992-11998 (2001).
165. Tiegs, G., Hentschel, J. & Wendel, A. A T-cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203 (1992).
166. Tiegs, G. Experimental hepatitis and role of cytokines. Acta Gastroenterol. Belg. 60, 176-179 (1997).
167. + T cells in transgenic mice expresing H-2Kb in the liver. Eur. J. Immunol. 25, 1932-1942 (1995).
168. Ando, K. et al. Mechanisms of class-1-restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541-1554 (1993).
169. Nakamoto, Y., Guidotti, L. G., Pasquetto, V., Schreiber, R. D. & Chisari, F. V. Differential target-cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158, 5692-5697 (1997).